Iovance Biotherapeutics (IOVA) Inventory Average (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Inventory Average of $55.0 million for Q1 2026, down 5.99% year-over-year from $58.5 million in Q1 2025, and up 6.45% quarter-over-quarter from $51.7 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Inventory Average (2023 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Inventory Average for 4 consecutive years, with $55.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average fell 5.99% year-over-year to $55.0 million; the TTM figure through Mar 2026 stood at $55.0 million (down 5.99% YoY), while the FY2025 annual figure was $51.6 million, up 66.74% from the prior year.
- Inventory Average grew to $55.0 million in Q1 2026 per IOVA's latest filing, from $51.7 million in the prior quarter.
- Across five years, Inventory Average topped out at $58.5 million in Q1 2025 and bottomed at $9.5 million in Q3 2023.
- Historically, Inventory Average has averaged $38.4 million across 4 years, with a median of $51.2 million in 2025.
- Annual changes were most pronounced in 2025 — Inventory Average surged 318.25% — and 2026, when it fell 5.99%.
- Iovance Biotherapeutics' Inventory Average stood at $9.8 million in 2023, then soared by 43.04% to $14.0 million in 2024, then soared by 269.39% to $51.7 million in 2025, then gained by 6.45% to $55.0 million in 2026.
- Business Quant data shows IOVA's Inventory Average at $55.0 million in Q1 2026, $51.7 million in Q4 2025, and $50.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | 56.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.98 Mn |
| Mar 31, 2026 | 55.03 Mn |
| Dec 31, 2025 | 51.69 Mn |
| Sep 30, 2025 | 50.77 Mn |
| Jun 30, 2025 | 57.69 Mn |
| Mar 31, 2025 | 58.53 Mn |
| Mar 31, 2024 | 13.99 Mn |
| Dec 31, 2023 | 9.78 Mn |
| Sep 30, 2023 | 9.46 Mn |